SCHEMBL963107

SCHEMBL963107

CCCCCC(C)(CCS(=O)(=O)c1nnnn1-c1ccccc1)O[Si](C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 15/20 0.50
MAPT P10636 8/20 0.50
LMNA P02545 8/20 0.50
HTT P42858 7/20 0.50
TP53 P04637 6/20 0.50
NPSR1 Q6W5P4 5/20 0.50
HPGD P15428 4/20 0.50
HSD17B10 Q99714 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
KMT2A Q03164 3/20 0.49
S1PR4 O95977 2/20 0.49
S1PR1 P21453 2/20 0.49
RAB9A P51151 2/20 0.49
MAPK1 P28482 2/20 0.49
PTPRB P23467 1/20 0.45
GFER P55789 1/20 0.36
TSHR P16473 3/20 0.35
MEN1 O00255 1/20 0.35
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1576966 0.97 ALDH1A1 (0.51) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL31117253 0.89 ALDH1A1 (0.50) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL1575889 0.85 ALDH1A1 (0.50) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL959865 0.84 ALDH1A1 (0.52) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL17511740 0.82 ALDH1A1 (0.63) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL1286389 0.82 ALDH1A1 (0.47) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL31117574 0.82 ALDH1A1 (0.47) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL1576637 0.82 ALDH1A1 (0.50) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL1980247 0.81 ALDH1A1 (0.61) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL16218976 0.81 ALDH1A1 (0.61) ALDH1A1MAPTLMNAHTTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501793-B2 Blood flow promoters for cauda equina tissues ONO PHARMACEUTICAL CO., LTD. (JP) 2013-08-06 US disclosed
US-20130143934-A1 AGENT FOR REGENERATION AND/OR PROTECTION OF NERVES ONO PHARMACEUTICAL CO., LTD. (JP) 2013-06-06 US disclosed
US-8404858-B2 Agent for regeneration and/or protection of nerves ONO PHARMACEUTICAL CO., LTD. (JP) 2013-03-26 US disclosed
EP-2494990-A1 Agent for regeneration and/or protection of nerves ONO PHARMACEUTICAL CO., LTD. (JP) 2012-09-05 EP disclosed
EP-2308510-A1 Agent for regeneration and/or protection of nerves Ono Pharmaceutical Co., Ltd. (JP) 2011-04-13 EP disclosed
US-20110059920-A1 AGENT FOR REGENERATION AND/OR PROTECTION OF NERVES ONO PHARMACEUTICAL CO., LTD (JP) 2011-03-10 US disclosed
US-20110015238-A1 BLOOD FLOW PROMOTERS FOR CAUDA EQUINA TISSUES ONO PHARMACEUTICAL CO., LTD. (JP) 2011-01-20 US disclosed
US-7863263-B2 Agent for regeneration and/or protection of nerves ONO PHARMACEUTICAL CO., LTD. (JP) 2011-01-04 US disclosed
US-7833995-B2 Blood flow promoters for cauda equina tissues ONO PHARMACEUTICAL CO., LTD. (JP) 2010-11-16 US disclosed
US-20090227644-A1 AGENT FOR REGENERATION AND/OR PROTECTION OF NERVES ONO PHARMACEUTICAL CO., LTD (JP) 2009-09-10 US disclosed
EP-1886693-A1 AGENT FOR REGENERATION AND/OR PROTECTION OF NERVES ONO PHARMACEUTICAL CO., LTD. (JP) 2008-02-13 EP disclosed
US-20070129327-A1 Blood flow promoters for cauda equina tissues ONO PHARMACEUTICAL CO., LTD. (JP) 2007-06-07 US disclosed
EP-1707208-A1 BLOOD FLOW PROMOTERS FOR CAUDA EQUINA TISSUES ONO PHARMACEUTICAL CO., LTD. (JP) 2006-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129327-A1 Blood flow promoters for cauda equina tissues PTGFR, PTGIS, PTGIR ALDH1A1 427/4885MAPT 3722/4885LMNA 1814/4885
US-20130143934-A1 AGENT FOR REGENERATION AND/OR PROTECTION OF NERVES PTGER3, PTGER2, PTGER1 ALDH1A1 1947/4885MAPT 4554/4885LMNA 777/4885
US-20110015238-A1 BLOOD FLOW PROMOTERS FOR CAUDA EQUINA TISSUES PTGFR, PTGIS, PTGIR ALDH1A1 427/4885MAPT 3722/4885LMNA 1814/4885
US-20090227644-A1 AGENT FOR REGENERATION AND/OR PROTECTION OF NERVES PTGER3, PTGER2, PTGER1 ALDH1A1 1947/4885MAPT 4554/4885LMNA 777/4885
US-20110059920-A1 AGENT FOR REGENERATION AND/OR PROTECTION OF NERVES PTGER3, PTGER2, PTGER1 ALDH1A1 1947/4885MAPT 4554/4885LMNA 777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.